These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7509569)

  • 1. Detection of fetal Turner syndrome with multiple-marker screening.
    Wenstrom KD; Williamson RA; Grant SS
    Am J Obstet Gynecol; 1994 Feb; 170(2):570-3. PubMed ID: 7509569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.
    Wenstrom KD; Boots LR; Cosper PC
    J Matern Fetal Med; 1996; 5(1):31-5. PubMed ID: 8796763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.
    Saller DN; Canick JA; Schwartz S; Blitzer MG
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1021-4. PubMed ID: 1384332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
    Burton BK; Prins GS; Verp MS
    Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.
    Wenstrom KD; Desai R; Owen J; DuBard MB; Boots L
    Am J Obstet Gynecol; 1995 Oct; 173(4):1287-92. PubMed ID: 7485339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.
    Nyberg DA; Luthy DA; Cheng EY; Sheley RC; Resta RG; Williams MA
    Am J Obstet Gynecol; 1995 Oct; 173(4):1030-5. PubMed ID: 7485289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
    Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
    Huderer-Duric K; Skrablin S; Kuvacic I; Sonicki Z; Rubala D; Suchanek E
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):49-55. PubMed ID: 10659916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum screening.
    Carroll JC
    Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
    Bahado-Singh R; Shahabi S; Karaca M; Mahoney MJ; Cole L; Oz UA
    Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome.
    Benn PA; Horne D; Briganti S; Greenstein RM
    Am J Obstet Gynecol; 1995 Aug; 173(2):496-501. PubMed ID: 7544068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
    Wenstrom KD; Owen J; Chu Dc; Boots L
    Am J Obstet Gynecol; 1999 Oct; 181(4):887-92. PubMed ID: 10521748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.